Sareum Share Price (SAR)
SAR Share
SAR Share
SAR Share
SAR Share
SAR
SAR Share
SAR Level 2
SAR Live
SAR Broker
SAR Directors
SAR Financial
SAR
SAR Short
SAR
Last checked at -
| Sareum Share Price | |
|---|---|
| Price | 0.395 |
| Bid | 0.39 |
| Ask | 0.40 |
| Change | 0.00 (0.00%) |
| Volume | 1,677,626 |
| Open | 0.395 |
| High | 0.395 |
| Low | 0.395 |
| Close | 0.395 |
| Currency | GBX |
| Currency | GBX |
|---|---|
| Issue Country | GB |
| Shares in Issue | 3,071m |
| Market Capitalisation | £12m |
| Market Size | 300,000 |
| 52 Week High | 0.895 |
| 52 Week High Date | 03-Aug-2018 |
| 52 Week Low | 0.385 |
| 52 Week Low Date | 12-Jul-2019 |
| # Trades | 7 |
|---|---|
| Vol. Sold | 817,318 |
| Sold Value | £3,228 |
| Vol. Bought | 860,308 |
| Bought Value | £3,398 |
| PE Ratio | -7.90 |
| Earnings | -0.05 |
| Dividend | 0.00 |
| Yield | 0.00% |
| Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
|---|---|---|---|---|---|---|---|---|
| 17-Jul-19 | 10:25:24 | 0.397 | 248,879 | Buy* | 0.39 | 0.40 | 988.05 | O Ordinary |
| 17-Jul-19 | 10:15:53 | 0.39 | 32,902 | Sell* | 0.39 | 0.40 | 128.32 | O Ordinary |
| 17-Jul-19 | 09:39:25 | 0.397 | 500,882 | Buy* | 0.39 | 0.40 | 1,989 | O Ordinary |
| 17-Jul-19 | 09:32:42 | 0.397 | 75,547 | Buy* | 0.39 | 0.40 | 300.00 | O Ordinary |
| 17-Jul-19 | 08:32:17 | 0.39 | 750,000 | Sell* | 0.39 | 0.40 | 2,925 | O Ordinary |
| 17-Jul-19 | 08:27:20 | 0.391 | 34,416 | Sell* | 0.39 | 0.40 | 134.50 | O Ordinary |
| 17-Jul-19 | 08:06:20 | 0.40 | 35,000 | Buy* | 0.39 | 0.40 | 140.00 | O Ordinary |
| 16-Jul-19 | 16:14:57 | 0.398 | 27,390 | Buy* | 0.39 | 0.40 | 109.01 | O Ordinary |
| 16-Jul-19 | 15:54:23 | 0.398 | 87,500 | Buy* | 0.39 | 0.40 | 348.25 | O Ordinary |
| 16-Jul-19 | 15:40:58 | 0.398 | 123,743 | Buy* | 0.39 | 0.40 | 492.50 | O Ordinary |
| Trade Date | Action | Notifier | Price | Currency | Amount | Holding |
|---|---|---|---|---|---|---|
| 08-Mar-17 | Buy | Stephen Parker held the position of Non-Executive Chairman at the time of this trade. Stephen Parker | 0.95 | GBX | 674,272 | 674,272 |
| 08-Mar-17 | Buy | Stephen Parker held the position of Non-Executive Chairman at the time of this trade. Stephen Parker | 0.95 | GBX | 461,949 | 674,272 |
| 07-Mar-11 | Sell | Timothy J Mitchell held the position of CEO at the time of this trade. Timothy J Mitchell | 2.45 | GBX | 250,000 | 42,280,471 |
| 07-Mar-11 | Sell | Timothy J Mitchell held the position of CEO at the time of this trade. Timothy J Mitchell | 2.45 | GBX | 250,000 | 0 |
| 30-Jun-09 | Notification of Holding | Dr Paul B Harper held the position of Non-Executive Chairman at the time of this trade. Dr Paul B Harper | 0.00 | 0 | 0 |
Sareum’s small molecule drug discovery expertise builds value by developing drug candidates, focused on cancer and autoimmune disease, for licencing to pharmaceutical and biotechnology companies.
Last checked at